Surgical Outcomes for Obstructive Total Anomalous Pulmonary Venous Return of the Non-Infracardiac Type Compared with the Infracardiac Type
Repair of Obstructive and Non-infracardiac TAPVR
DOI:
https://doi.org/10.1532/hsf.3217Keywords:
Total anomalous pulmonary venous return, obstructive type, non-infracardiac typeAbstract
Background: Infracardiac obstructive total anomalous pulmonary venous return (TAPVR) has a poor outcome following surgical correction. We compared the surgical outcomes of obstructive TAPVR between non-infracardiac and infracardiac types.
Methods: Among 51 patients who underwent surgical repair for obstructive TAPVR, 23 with infracardiac type and 28 with non-infracardiac type were included in this investigation. The study compared the immediate postoperative courses in the intensive care unit and long-term mortality and pulmonary vein stenosis. The risk factors for long-term survival in obstructive TAPVR also were investigated.
Results: The postoperative follow-up period was 79.8 ± 81.5 months. Immediate major operative complications were observed in 22 patients (43.1%); 10 patients (19.6%) died, and eight patients (15.7%) experienced pulmonary vein stenosis during the follow-up period. The Kaplan-Meier curve showed better cumulative survival in patients with infracardiac TAPVR (P = 0.308). The significant factors for survival after surgical repair of obstructive TAPVR did not include anatomical type but instead were postoperative course of ventilator care and lengths of intensive care unit and hospital stays.
Conclusion: Patients with non-infracardiac TAPVR with obstruction had a longer postoperative course and experienced more complications. Their survival rate was poorer, and postoperative pulmonary vein stenosis was more frequent in those patients compared with infracardiac TAPVR patients. However, a large-scale study is mandatory to gather more data and confirm our findings.
References
Anil Kumar D, Kumar RN, Narasinga Rao P, et al. 2003. Repair of total anomalous pulmonary venous connection in early infancy. Asian Cardiovasc Thorac Ann 11:18-22.
Craig JM, Darling RC, Rothney WB. 1957. Total pulmonary venous drainage into the right side of the heart; report of 17 autopsied cases not associated with other major cardiovascular anomalies. Lab Invest 6:44-64.
Hancock Friesen CL, Zurakowski D, Thiagarajan RR, et al. 2005. Total anomalous pulmonary venous connection: an analysis of current management strategies in a single institution. Ann Thorac Surg 79:596-606; discussion 596-606.
Hawkins JA, Minich LL, Tani LY, Ruttenberg HD, Sturtevant JE, McGough EC. 1995. Absorbable polydioxanone suture and results in total anomalous pulmonary venous connection. Ann Thorac Surg 60:55-9.
Higaki T, Yamamoto E, Nakano T, et al. 2010. Successful stenting of the ductus venosus in 2 neonates with asplenia syndrome complicated by infracardiac type total anomalous pulmonary venous connection. J Cardiol Cases 1:e129-e32.
Husain SA, Maldonado E, Rasch D, et al. 2012. Total anomalous pulmonary venous connection: factors associated with mortality and recurrent pulmonary venous obstruction. Ann Thorac Surg 94:825-31; discussion 31-2.
Jinghao Z, Botao G, Zhiwei X, Jinfeng L. 2014. The research on operation of obstructed total anomalous pulmonary venous connection in neonates. Scientific World Journal 2014:576569.
Karamlou T, Gurofsky R, Al Sukhni E, et al. 2007. Factors associated with mortality and reoperation in 377 children with total anomalous pulmonary venous connection. Circulation 115:1591-8.
Kirshbom PM, Myung RJ, Gaynor JW, et al. 2002. Preoperative pulmonary venous obstruction affects long-term outcome for survivors of total anomalous pulmonary venous connection repair. Ann Thorac Surg 74:1616-20.
Lemaire A, DiFilippo S, Parienti JJ, et al. 2017. Total Anomalous Pulmonary Venous Connection: A 40 years' Experience Analysis. Thorac Cardiovasc Surg 65:9-17.
Michielon G, Di Donato RM, Pasquini L, et al. 2002. Total anomalous pulmonary venous connection: long-term appraisal with evolving technical solutions. Eur J Cardiothorac Surg 22:184-91.
Modi A, Vohra HA, Brown I, Langley SM. 2008. Successful surgical correction of total anomalous pulmonary venous drainage in the sixth decade. Ann Thorac Surg 86:1684-6.
Seale AN, Uemura H, Webber SA, et al. 2010. Total anomalous pulmonary venous connection: morphology and outcome from an international population-based study. Circulation 122:2718-26.
Shaw FR, Chen JM. 2017. Surgical Considerations in Total Anomalous Pulmonary Venous Connection. Semin Cardiothorac Vasc Anesth 21:132-37.
Shi G, Zhu Z, Chen J, et al. 2017. Total Anomalous Pulmonary Venous Connection: The Current Management Strategies in a Pediatric Cohort of 768 Patients. Circulation 135:48-58.
Yong MS, d'Udekem Y, Robertson T, et al. 2011. Outcomes of surgery for simple total anomalous pulmonary venous drainage in neonates. Ann Thorac Surg 91:1921-7.
Published
How to Cite
Issue
Section
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).
